PCN144 The Comparative Pharmacoeconomic Analysis of Using Cabozantinib As Second-LINE Therapy for Adult Patients with Metastatic Renal Cell Carcinoma in Russia
Dec 1, 2020, 00:00 AM
10.1016/j.jval.2020.08.281
https://www.valueinhealthjournal.com/article/S1098-3015(20)32537-7/fulltext
Section Title :
Section Order :
10221
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32537-7&doi=10.1016/j.jval.2020.08.281